News of the American College of Cardiology Congress
Professor Naufal Zagidullin talks about Sofya Sovetova, who presented her poster report at the congress.
Research STEP-HFpEF DM. Patients with heart failure with preserved ejection fraction related to obesity and type 2 diabetes ashowed significant improvement in symptoms and exercise tolerance after 1 year of semaglutide therapy despite less weight loss compared to patients without diabetes
In a study of patients with atherosclerotic cardiovascular diseases, the strategy using Inclisiran led to a reduction in LDL compared to standard therapy without adjustments for statin safety.
Research ULTIMATE-DAPT: most patients with ACS can safely discontinue aspirin 1 month after coronary intervention
Monotherapy with ticagrelor 1 month after the start of dual antiplatelet therapy DAPT) showed advantages over the 12-month DAPT (aspirin + ticagrelor) of intracoronary intervention in reducing significant bleeding without increasing the risk of thrombosis.
Double-blind study TACT2: Chelation (using EDTA) does not improve outcomes after MI in patients with type 2 diabetes during 48 months of observation
In the research REDUCE-AMI in patients with myocardial infarction and preserved ejection fraction, the reduction in the use of beta-blockers (bisoprolol or metoprolol) did not lead to a decrease in all-cause mortality or future myocardial infarctions compared to standard therapy
